Market Research Logo

Australia Pharmaceuticals and Healthcare Report Q1 2016

Australia Pharmaceuticals and Healthcare Report Q1 2016

BMI View: The prevailing trend of austerity targeting pharmaceuticals and healthcare spending inAustralia will continue to weigh on the country's attractiveness to innovative drugmakers. On top of this,ongoing political instability and policy uncertainty have moderated the confidence to invest in Australia,with cooperation between the government and the pharmaceutical industry remaining sparse as theirrelations come under strain. Meanwhile, although the Trans-Pacific Partnership's latest outcome confirmsAustralia's attempt to balance incentives to innovation in the biopharmaceutical industry with costcontainment concerns, the recent creation of a medical-research fund will provide some level of governmentsupport for research and innovation initiatives in the sector, albeit under a gradual and phased multi-yearhorizon.

Headline Expenditure Projections

Pharmaceuticals: AUD13.48bn (USD12.15bn) in 2014 to AUD13.99bn (USD10.35bn) in 2015; +3.7%in local currency terms and -14.8% in US dollar terms, due to significant exchange ratefluctuations. Forecast in line with last quarter.


BMI Industry View
Table: Headline Pharmaceuticals & Healthcare Forecasts (2013-2019)
SWOT
Industry Forecast
Pharmaceutical Market Forecast
Table: Pharmaceutical Sales, Historical Data And Forecasts (Australia 2011-2019)
Healthcare Market Forecast
Table: Selected Health Measures In Australia FY2015/16 Budget
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Australia 2011-2019)
Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (Australia 2011-2019)
Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (Australia 2011-2019)
Prescription Drug Market Forecast
Table: Prescription Drug Market Indicators, Historical Data And Forecasts (Australia 2011-2019)
Patented Drug Market Forecast
Table: Patented Drug Market Indicators, Historical Data And Forecasts (Australia 2011-2019)
Generic Drug Market Forecast
Table: Cost Of Selected Drugs Post-Price Disclosure, April 2013
Table: Generic Drug Market Indicators, Historical Data And Forecasts (Australia 2011-2019)
OTC Medicines Market Forecast
Table: Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts (Australia 2011-2019)
Pharmaceutical Trade Forecast
Table: Pharmaceutical Trade Data And Forecasts (Australia 2013-2019)
Table: Pharmaceutical Trade Data And Forecasts local currency (Australia 2013-2019)
Industry Risk Reward Index
Asia Pacific Risk/Reward Index
Australia Risk/Reward Index
Rewards
Risks
Regulatory Review
Table: EU & ICH Guidelines Adopted In The TGA's Biosimilars Guidance Document
Intellectual Property Issues
Pricing & Reimbursement Regime
Table: Selected Drugs Undergoing SPD (AUD)
Table: Historical PBS Co-Payments
Table: New PBS Formularies
Market Overview
Healthcare Sector
Research And Development
Clinical Trials
Epidemiology
Competitive Landscape
Research-Based Industry
Company Developments
Table: Multinational Market Activity
Pharmaceutical Distribution
Company Profile
Australian Pharmaceutical Industries
CSL
GlaxoSmithKline
Mayne Pharma Group
Sanofi
Sigma
Demographic Forecast
Table: Population Headline Indicators (Australia 1990-2025)
Table: Key Population Ratios (Australia 1990-2025)
Table: Urban/Rural Population & Life Expectancy (Australia 1990-2025)
Table: Population By Age Group (Australia 1990-2025)
Table: Population By Age Group % (Australia 1990-2025)
Glossary
Methodology
Pharmaceutical Expenditure Forecast Model
Healthcare Expenditure Forecast Model
Notes On Methodology
Risk/Reward Index Methodology
Index Overview
Table: Pharmaceutical Risk/Reward Index Indicators
Indicator Weightings

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report